Science Talk

When Sue Vincent learned in 2010 that her ovarian cancer had spread to three different parts of her body and was inoperable, she resigned herself to having only months to live. But then she was offered a place on a clinical trial for a pioneering drug called olaparib, the discovery and development of which was underpinned by our research. 12 years on, Sue is still taking olaparib, and explains how the work of our scientists has given her a quality of life she could only have dreamed about.

Professor Vlad Pena recently joined the Division of Structural Biology at The Institute of Cancer Research. Juanita Bawagan spoke to him about his research on splicing, a vital process in cells that can cause disease when gone awry.

Ben Kolbington reflects on the first day of the 15th NCRI conference in Glasgow, in which a key theme was turning research advances into practical and affordable solutions for improving patients’ lives.